BME PhD Defense: Diana Dillstrom

Systematic Optimization of Bone Pharmaceuticals to Maximize Therapeutic Response in Conditions of Low Bone Mass

Osteogenesis imperfecta (OI) is a genetic disorder caused by collagen-related mutations which leads to increased bone fragility and low bone...